Dr. Wang Yuan, chairman of 2Y-CHEM, Ltd. visited SCITECH pharm. Dr. Wang elaborated on the key elements in the research and development of new chemical drugs. Dr. Wang and SCITECH pharm team had in-depth exchanges on CMC information in drug registration application, potential problems causing CMC suspension, common problems in CMC declaration and key points of CMC in clinical trial application. Dr. Wang proposed that a good CMC in IND should be like telling a story that is easy to understand. In a simple and easy to understand form, it should reflect what your product is, how the product is developed, how the product is produced, how the product is detect, how the stability is, and how it is used in clinic. Dr. Wang will not only preach and solve puzzles for SCITECH pharm team, but also help the research and development of new molecular entities of SCITECH pharm chemistry, promote the drugs developed by SCITECH pharm to clinical as soon as possible, and provide more safe, effective, stable and controllable treatment drugs for patients.

来源：